Authors
Latest:
Dr Kaczmar on the Future Utility of Cemiplimab With Fianlimab in Advanced MelanomaJohn Michael Kaczmar, MD, discusses future implications for the use of fianlimab in combination with cemiplimab for the treatment of patients with advanced melanoma.
Latest:
Dr Katz on a Cystoscopic Cryocatheter in Bladder CancerAaron E. Katz, MD, discusses the rationale for and findings from a preclinical study evaluating the efficacy of a novel cystoscopic cryocatheter for in situ bladder cancer destruction.
Latest:
Barbara Ann Karmanos Cancer Institute and Wayne State University Name Boris C. Pasche, MD, PhD, FACP, President and Chief Executive OfficerThe Barbara Ann Karmanos Cancer Institute, part of Grand Blanc-based McLaren Health Care and a National Cancer Institute-designated Comprehensive Cancer Center, in conjunction with Wayne State University, have named Boris C. Pasche, MD, PhD, FACP, President & Chief Executive Officer and Chair of the Department of Oncology at the Wayne State University School of Medicine.
Latest:
Practical Advice for Management of Chronic GVHDThe panel provides advice for community providers treating patients with chronic GVHD, stressing effective communication, staying updated on evolving drugs, and collaborating with specialized multidisciplinary groups for optimal patient care.
Latest:
Rapid Readouts: Personalized versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomized, multicentre, open-label phase 2 trialRyan Hickey, MD, presents data from the American Society of Clinical Oncology 2021 Gastrointestinal Cancers Symposium on results of the phase 2 DOSISPHERE-01 trial of personalized vs standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma.
Latest:
Dr Amini on High-Risk Factors Associated With Cardiac Toxicities in Lung CancerArya Amini, MD, discusses cardiac toxicities associated with lung cancer.
Latest:
Investigators Explore Immunotherapy for NETs as Incidence GrowsTo date, oncologists have not seen much success with immunotherapy for neuroendocrine tumors.
Latest:
Dr Roland on a Study of Neoadjuvant Immune-Checkpoint Blockade Across Sarcoma SubtypesChristina L. Roland, MD, MS, FACS, discusses a study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma.
Latest:
Future Outlooks in the Treatment of R/R DLBCLShared insight on the future of diffuse large B-cell lymphoma management, highlighting unmet needs and hope for continued growth in the treatment landscape.
Latest:
How Bacteria Give Cancer a Helping HandTwo new studies show how bugs could help tumors progress and resist treatment.
Latest:
Pandemic Inspires New Outreach ProgramAs oncologists, we are here to help patients and their families as much as we can. That is why we went into cancer medicine. It is what we do every day. Until the coronavirus disease 2019 pandemic knocked on our doors.
Latest:
Dr Richter on the Current State of Bispecific Antibodies in Multiple MyelomaJoshua Richter, MD, discusses how bispecific antibodies fit into the current treatment armamentarium for patients with multiple myeloma, highlighting his presentation from the 41st Annual CFS®.
Latest:
Investigational Agents for Relapsed/Refractory MyelomaKeith Stewart, MD, ChB, MBA; Sagar Lonial, MD, FACP; Cristina Gasparetto, MD; Joseph Mikhael, MD; and Nina Shah, MD, review additional emerging agents in the pipeline for the treatment of RRMM; including BCMA-targeted bispecific antibodies.
Latest:
Dr. Fausel on the Evolution of Genomic Testing in Cancer CareChristopher A. Fausel, PharmD, MHA, BCOP, discusses how genetic sequencing has played a growing role in cancer care.
Latest:
Optimizing Treatment Selection for Patients with FLT3-ITD AMLDiscussion centered around optimal strategies to effectively treat, and improve outcomes for, patients with FLT3-ITD AML.
Latest:
Dr. Zeiser on Results of the REACH3 Trial in Chronic GVHDRobert Zeiser, MD, discusses results of the REACH3 trial in chronic graft-versus-host disease.
Latest:
Dr. Tilly on Pola-R-CHP in an Asia Subpopulation of Patients With DLBCLHervé Tilly, MD, PhD, discusses the efficacy of polatuzumab vedotin-piiq plus rituximab, cyclophosphamide, doxorubicin, and prednisone in an Asia subpopulation of patients with diffuse large B-cell lymphoma.
Latest:
Dr Birrer on Molecular Stratification in Endometrial CancerMichael J. Birrer, MD, PhD, discusses the benefits of molecular profiling in patients with endometrial cancer, the variety of mutations that have been identified in this disease, and how stratifying patients based on the biomarkers their disease harbors allows for more individualized treatment decisions.
Latest:
Dr. Ajani on the FDA Approvals of Nivolumab Plus Chemotherapy and Nivolumab Plus Ipilimumab in ESCCJaffer A. Ajani, MD, discusses how the FDA approvals of first-line nivolumab plus chemotherapy and nivolumab plus ipilimumab in advanced or metastatic esophageal squamous cell carcinoma will improve treatment in this setting.
Latest:
Dr. Hales on the Role of Multidisciplinary Care in Locally Advanced Lung CancerRussell Kenneth Hales, MD, discusses the role of multidisciplinary care in locally advanced lung cancer.
Latest:
Dr. Matsen on the Effects of Decreased Breast Cancer Screening in the COVID-19 EraCindy B. Matsen, MD, discusses the potential effects of the decrease in screening for patients with breast cancer during the coronavirus disease 2019 pandemic.
Latest:
Dr Rahimi on Escalating Preoperative, Single-Fraction Ablative Radiation in HR-Positive Breast CancerAsal Rahimi, MD, MS, discusses initial efficacy results from the expanded cohort of a phase 1 dose-escalation study (NCT04040569) evaluating pre-operative, single fraction stereotactic ablative radiation in early-stage, hormone receptor–positive breast cancer.
Latest:
Narsoplimab: The Phase 2 TrialSamer Khaled, MD reviews the design, results, and practical implications of the pivotal phase 2 trial of narsoplimab, a MASP-2 targeted monoclonal antibody under investigation for the treatment of thrombotic microangiopathy associated with hematopoietic stem cell transplantation.
Latest:
Advice for New Nurse Practitioners Working With Patients With Endometrial CancerClosing their discussion, the panel shares advice for new nurse practitioners caring for patients who have endometrial cancer.
Latest:
Evolving Psychosocial Care Models Step Forward as the Next Targeted Cancer TherapyDuring this search for a breast cancer support system, my mother also investigated complementary therapies that peers had used to help cope with their fears, adverse effects, and feelings of helplessness.
Latest:
Dr Kadia on Targeting the IRAK4 Pathway in AMLTapan M. Kadia, MD, discusses targeting the IRAK4 pathway in patients with acute myeloid leukemia and highlights the importance of utilizing targeted therapies in the treatment of patients with hematologic malignancies.
Latest:
Women in Oncology: Lessons to Tell Up-and-Coming Female OncologistsLaura Farrington, DO, Elesyia Outlaw-Evans, MD, and Ruchi Garg, MD, provide advice to female oncologists who are just starting out their careers.
Latest:
Dr. Lee on the Current State of Molecular Testing in Early-Stage NSCLCJay Moon Lee, MD, discusses the current state of molecular testing in early-stage non–small cell lung cancer.
Latest:
Breast Nerve Preservation and Grafting: How Surgeons Can Help Mitigate Sensation LossMore surgeons are having in-depth conversations with their patients with breast cancer and prophylactic patients about the fact that nerves will have to be cut during their mastectomy, how that will impact sensation and quality of life, and how surgeon collaboration and breast neurotization can help restore sensation.
Latest:
Women in Oncology: Prioritization and Passionate LegaciesSelina M. Luger, MD, FRCPC, Gail J. Roboz, MD, and Wendy Stock, MD, discuss how being female affected their careers and share the scientific achievements they most want to be remembered for in the leukemia field.
